Search results
Results from the WOW.Com Content Network
One point is assigned for each of the following risk factors: [citation needed] Age greater than 60 years; Stage III or IV disease; Elevated serum LDH; ECOG/Zubrod performance status of 2, 3, or 4; More than 1 extranodal site; The sum of the points allotted correlates with the following risk groups: Low risk (0-1 points) - 5-year survival of 73%
I – Investigated condition (e.g. intervention, exposure, risk/ prognostic factor, or test result) C – Comparison condition (e.g. intervention, exposure, risk/ prognostic factor, or test result respectively) O – Outcome(s) (e.g. symptom, syndrome, or disease of interest) Alternatives such as SPICE and PECO (among many others) can also be used.
A more refined prognosis can be established by consideration of prostate-specific antigen, and grade (i.e. Gleason score in the Gleason grading system). For example, it is common to classify patients into high, intermediate and low-risk groups on the basis of these three factors (TNM stage, PSA and Gleason score).
For example, a hazard ratio of 2 is thought to mean that a group has twice the chance of dying than a comparison group. In the Cox-model, this can be shown to translate to the following relationship between group survival functions : S 1 ( t ) = S 0 ( t ) r {\displaystyle S_{1}(t)=S_{0}(t)^{r}} (where r is the hazard ratio). [ 4 ]
One example of a prognostic biomarkers in clinical research, is the use of mutated PIK3CA in the study of metastatic breast cancer. As illustrated by the graph , the mutation is prognostic since its presence in the patient endure the same outcome regardless of the treatment method used.
In this way, investigators can eventually use the data to answer many questions about the associations between "risk factors" and disease outcomes. For example, one could identify smokers and non-smokers at baseline and compare their subsequent incidence of developing heart disease. Alternatively, one could group subjects based on their body ...
Prognosis (Greek: πρόγνωσις "fore-knowing, foreseeing"; pl.: prognoses) is a medical term for predicting the likelihood or expected development of a disease, including whether the signs and symptoms will improve or worsen (and how quickly) or remain stable over time; expectations of quality of life, such as the ability to carry out daily activities; the potential for complications and ...
The log-rank test compares the survival times of two or more groups. This example uses a log-rank test for a difference in survival in the maintained versus non-maintained treatment groups in the aml data. The graph shows KM plots for the aml data broken out by treatment group, which is indicated by the variable "x" in the data.